Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU
Status:
Terminated
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of intravenous micafungin
versus placebo as prophylactic therapy for invasive fungal infections in patients in the
intensive care unit considered to be at high risk.